← Back to All Filings

Research Solutions Director Granted 50,000 Stock Options

Low SignificanceDecember 16, 2025 at 6:33:16 PM EST

Research Solutions, Inc.

$RSSS4CIK: 0001386301

Subscribe to track RSSS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Research Solutions Director Granted 50,000 Stock Options

Company: Research Solutions, Inc. (RSSS) Form: 4 | Filed: 2025-12-16 Significance: Low

Insider: Gayron Kenneth L Title: Director

Transaction: • Type: Grant (Stock Option) • Shares: 50,000 • Price: $0.00 • Value: $0 • Owned After: 50,000 options

Key Insight: A director received a routine grant of 50,000 stock options, representing a potential 0.15% dilution upon exercise.

Market Context: This is a standard form of non-cash compensation for a director in a small-cap company, with a vesting schedule over several years.

Comprehensive Analysis

SEC Filing Analysis: Research Solutions, Inc. (RSSS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director was granted 50,000 stock options as part of a standard compensation package.
  • Market Impact: The transaction is a routine compensation event and is not expected to have a material impact on the stock.

Company Information

FieldValue
CompanyResearch Solutions, Inc.
Ticker SymbolRSSS
CIK0001386301
IndustrySERVICES-BUSINESS SERVICES, NEC

Insider Information

FieldValue
NameGayron Kenneth L
CIK0001669103
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-12
Transaction CodeA (Grant)
Security TypeOption to purchase common stock
Shares Involved50,000
Price Per Share$0.00
Total Value$0
Shares Owned After50,000 (options)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted50,000 (underlying shares)
% of Shares Outstanding0.15%
Post-Transaction Ownership50,000 options
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The grant has no immediate cash value and is immaterial against the company's $110 million market capitalization.
  • Ownership Concentration: This grant establishes the director's derivative position in the company.
  • Dilution Impact: The potential dilution from these options, if exercised, is minor at approximately 0.15% of the current shares outstanding.
  • Transaction Significance: The transaction is considered routine director compensation and carries low significance as it is not an open-market trade reflecting insider sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Equity grants are a standard form of compensation and do not signal a change in an insider's view of the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: None. This is not a market transaction.
  • Sentiment Indicator: Neutral. The grant is a routine corporate action.

Additional Context

Transaction Notes

  • Vesting Schedule: The options vest over time. 1/3rd vest one year from the grant date, with the remainder vesting quarterly thereafter until fully vested.
  • Expiration: The options expire on November 11, 2035.
Topics:#SECFiling#InsiderTrading#RSSS#ResearchSolutions#Form4#StockOptions#DirectorGrant#Investing#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.